comparemela.com

Latest Breaking News On - Berlin heals holding - Page 1 : comparemela.com

Berlin Heals Holding AG welcomes Dr Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

Berlin Heals Holding AG Successfully Completes Financing Round for Ongoing CE-Study

/PRNewswire/ Berlin Heals Holding AG, a MedTech startup, has developed a breakthrough method and a product for the therapy of heart failure. The product -.

Berlin Heals Holding AG receives further financing for revolutionary heart implant

/PRNewswire/ Berlin Heals Holding AG (Berlin Heals), a Swiss MedTech company that has developed a completely new and groundbreaking method for the therapy.

Investegate |Berlin Heals Holding AG Announcements | Berlin Heals Holding AG: BERLIN HEALS Receive Breakthrough Device Designation from FDA for its C-MIC Heart Failure Device and Initiates Early Feasibility Study in the United States

Berlin Heals Holding AG BERLIN HEALS Receive Breakthrough Device Designation from FDA for its C-MIC Heart Failure Device and Initiates Early Feasibility Study in the United States BERLIN HEALS Receive Breakthrough Device Designation from FDA for its C-MIC Heart Failure Device and Initiates Early Feasibility Study in the United States BERLIN and ZUG, Switzerland, March 11, 2021 (GLOBE NEWSWIRE) BERLIN HEALS, a company developing novel life-saving treatments for heart failure, announced today that the US Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for its proprietary Cardiac Microcurrent Therapy Device ( C-MIC ). The C-MIC is an implantable device that delivers a constant but minimal electrical DC-current to the heart via two electrodes. Based on results of first-in-human studies in 2019/20, the C-MIC device has shown potential to become the first near-curative heart failure therapy. Berlin Heals, which has already launched a European-wide CE

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.